{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T11:25:49Z","timestamp":1749727549723,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":30,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071626504"},{"type":"electronic","value":"9781071626511"}],"license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2651-1_33","type":"book-chapter","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T19:08:04Z","timestamp":1670526484000},"page":"363-374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Challenges of Treatment Methodologies and the Future of Gene Therapy and Stem Cell Therapy to Treat Retinitis Pigmentosa"],"prefix":"10.1007","author":[{"given":"Angela Y.","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"9549","key":"33_CR1","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/s0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet (London, England) 368(9549):1795\u20131809. https:\/\/doi.org\/10.1016\/s0140-6736(06)69740-7","journal-title":"Lancet (London, England)"},{"issue":"4","key":"33_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/apo.0000000000000227","volume":"5","author":"Q Zhang","year":"2016","unstructured":"Zhang Q (2016) Retinitis pigmentosa: progress and perspective. Asia Pac J Ophthalmol (Phila) 5(4):265\u2013271. https:\/\/doi.org\/10.1097\/apo.0000000000000227","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"8","key":"33_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/aos.13141","volume":"94","author":"DS Narayan","year":"2016","unstructured":"Narayan DS, Wood JP, Chidlow G et al (2016) A review of the mechanisms of cone degeneration in retinitis pigmentosa. Acta Ophthalmol 94(8):748\u2013754. https:\/\/doi.org\/10.1111\/aos.13141","journal-title":"Acta Ophthalmol"},{"key":"33_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3389\/fnins.2019.00945","volume":"13","author":"P Vagni","year":"2019","unstructured":"Vagni P, Perlini LE, Chenais NAL et al (2019) Gene editing preserves visual functions in a mouse model of retinal degeneration. Front Neurosci 13:945. https:\/\/doi.org\/10.3389\/fnins.2019.00945","journal-title":"Front Neurosci"},{"issue":"2","key":"33_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1089\/hum.2015.147","volume":"27","author":"D Dalkara","year":"2016","unstructured":"Dalkara D, Goureau O, Marazova K et al (2016) Let there be light: gene and cell therapy for blindness. Hum Gene Ther 27(2):134\u2013147. https:\/\/doi.org\/10.1089\/hum.2015.147","journal-title":"Hum Gene Ther"},{"key":"33_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fnins.2017.00174","volume":"11","author":"GA Ochakovski","year":"2017","unstructured":"Ochakovski GA, Bartz-Schmidt KU, Fischer MD (2017) Retinal gene therapy: surgical vector delivery in the translation to clinical trials. Front Neurosci 11:174\u2013174. https:\/\/doi.org\/10.3389\/fnins.2017.00174","journal-title":"Front Neurosci"},{"issue":"1","key":"33_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/14712598.2018.1389886","volume":"18","author":"NA Moore","year":"2018","unstructured":"Moore NA, Morral N, Ciulla TA et al (2018) Gene therapy for inherited retinal and optic nerve degenerations. Expert Opin Biol Ther 18(1):37\u201349. https:\/\/doi.org\/10.1080\/14712598.2018.1389886","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"33_CR8","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1172\/jci82462","volume":"125","author":"SF Koch","year":"2015","unstructured":"Koch SF, Tsai YT, Duong JK et al (2015) Halting progressive neurodegeneration in advanced retinitis pigmentosa. J Clin Invest 125(9):3704\u20133713. https:\/\/doi.org\/10.1172\/jci82462","journal-title":"J Clin Invest"},{"issue":"3","key":"33_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/21678707.2018.1444476","volume":"6","author":"C Martinez-Fernandez De La Camara","year":"2018","unstructured":"Martinez-Fernandez De La Camara C, Nanda A, Salvetti AP et al (2018) Gene therapy for the treatment of X-linked retinitis pigmentosa. Expert Opin Orphan Drugs 6(3):167\u2013177. https:\/\/doi.org\/10.1080\/21678707.2018.1444476","journal-title":"Expert Opin Orphan Drugs"},{"issue":"6","key":"33_CR10","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1096\/fj.15-270363","volume":"29","author":"Z Han","year":"2015","unstructured":"Han Z, Banworth MJ, Makkia R et al (2015) Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype. FASEB J 29(6):2535\u20132544. https:\/\/doi.org\/10.1096\/fj.15-270363","journal-title":"FASEB J"},{"issue":"22","key":"33_CR11","doi-asserted-by":"publisher","first-page":"6446","DOI":"10.1093\/hmg\/ddv354","volume":"24","author":"S Mookherjee","year":"2015","unstructured":"Mookherjee S, Hiriyanna S, Kaneshiro K et al (2015) Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy. Hum Mol Genet 24(22):6446\u20136458. https:\/\/doi.org\/10.1093\/hmg\/ddv354","journal-title":"Hum Mol Genet"},{"key":"33_CR12","first-page":"2479","volume":"18","author":"B Rossmiller","year":"2012","unstructured":"Rossmiller B, Mao H, Lewin AS (2012) Gene therapy in animal models of autosomal dominant retinitis pigmentosa. Mol Vis 18:2479\u20132496","journal-title":"Mol Vis"},{"issue":"21","key":"33_CR13","doi-asserted-by":"publisher","first-page":"11488","DOI":"10.1073\/pnas.210319397","volume":"97","author":"MM LaVail","year":"2000","unstructured":"LaVail MM, Yasumura D, Matthes MT et al (2000) Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy. Proc Natl Acad Sci U S A 97(21):11488\u201311493. https:\/\/doi.org\/10.1073\/pnas.210319397","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"33_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/emmm.201000119","volume":"3","author":"C Mussolino","year":"2011","unstructured":"Mussolino C, Sanges D, Marrocco E et al (2011) Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa. EMBO Mol Med 3(3):118\u2013128. https:\/\/doi.org\/10.1002\/emmm.201000119","journal-title":"EMBO Mol Med"},{"issue":"3","key":"33_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/mt.2015.220","volume":"24","author":"B Bakondi","year":"2016","unstructured":"Bakondi B, Lv W, Lu B et al (2016) In vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa. Mol Ther 24(3):556\u2013563. https:\/\/doi.org\/10.1038\/mt.2015.220","journal-title":"Mol Ther"},{"key":"33_CR16","doi-asserted-by":"publisher","first-page":"14716","DOI":"10.1038\/ncomms14716","volume":"8","author":"W Yu","year":"2017","unstructured":"Yu W, Mookherjee S, Chaitankar V et al (2017) Nrl knockdown by AAV-delivered CRISPR\/Cas9 prevents retinal degeneration in mice. Nat Commun 8:14716. https:\/\/doi.org\/10.1038\/ncomms14716","journal-title":"Nat Commun"},{"issue":"11","key":"33_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.92","volume":"5","author":"MC Latella","year":"2016","unstructured":"Latella MC, Di Salvo MT, Cocchiarella F et al (2016) In vivo editing of the human mutant rhodopsin gene by electroporation of plasmid-based CRISPR\/Cas9 in the mouse retina. Mol Ther Nucleic Acids 5(11):e389. https:\/\/doi.org\/10.1038\/mtna.2016.92","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"33_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1172\/JCI21686","volume":"114","author":"A Otani","year":"2004","unstructured":"Otani A, Dorrell MI, Kinder K et al (2004) Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. J Clin Invest 114(6):765\u2013774. https:\/\/doi.org\/10.1172\/JCI21686","journal-title":"J Clin Invest"},{"issue":"6","key":"33_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1172\/JCI22930","volume":"114","author":"LEH Smith","year":"2004","unstructured":"Smith LEH (2004) Bone marrow-derived stem cells preserve cone vision in retinitis pigmentosa. J Clin Invest 114(6):755\u2013757. https:\/\/doi.org\/10.1172\/JCI22930","journal-title":"J Clin Invest"},{"issue":"1","key":"33_CR20","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.2119\/molmed.2012.00242","volume":"18","author":"Y Li","year":"2012","unstructured":"Li Y, Tsai Y-T, Hsu C-W et al (2012) Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Mol Med 18(1):1312\u20131319. https:\/\/doi.org\/10.2119\/molmed.2012.00242","journal-title":"Mol Med"},{"issue":"7116","key":"33_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nature05161","volume":"444","author":"RE MacLaren","year":"2006","unstructured":"MacLaren RE, Pearson RA, MacNeil A et al (2006) Retinal repair by transplantation of photoreceptor precursors. Nature 444(7116):203\u2013207. https:\/\/doi.org\/10.1038\/nature05161","journal-title":"Nature"},{"issue":"1","key":"33_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13287-015-0020-6","volume":"6","author":"RC Siqueira","year":"2015","unstructured":"Siqueira RC, Messias A, Messias K et al (2015) Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell-clinical trial). Stem Cell Res Ther 6(1):29\u201329. https:\/\/doi.org\/10.1186\/s13287-015-0020-6","journal-title":"Stem Cell Res Ther"},{"issue":"9967","key":"33_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/s0140-6736(14)61376-3","volume":"385","author":"SD Schwartz","year":"2015","unstructured":"Schwartz SD, Regillo CD, Lam BL et al (2015) Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: follow-up of two open-label phase 1\/2 studies. Lancet (London, England) 385(9967):509\u2013516. https:\/\/doi.org\/10.1016\/s0140-6736(14)61376-3","journal-title":"Lancet (London, England)"},{"issue":"1","key":"33_CR24","doi-asserted-by":"publisher","first-page":"19969","DOI":"10.1038\/srep19969","volume":"6","author":"AG Bassuk","year":"2016","unstructured":"Bassuk AG, Zheng A, Li Y et al (2016) Precision medicine: genetic repair of retinitis pigmentosa in patient-derived stem cells. Sci Rep 6(1):19969. https:\/\/doi.org\/10.1038\/srep19969","journal-title":"Sci Rep"},{"issue":"1711","key":"33_CR25","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1098\/rspb.2010.1747","volume":"278","author":"E Zrenner","year":"2011","unstructured":"Zrenner E, Bartz-Schmidt KU, Benav H et al (2011) Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc Biol Sci 278(1711):1489\u20131497. https:\/\/doi.org\/10.1098\/rspb.2010.1747","journal-title":"Proc Biol Sci"},{"issue":"1757","key":"33_CR26","doi-asserted-by":"publisher","first-page":"20130077","DOI":"10.1098\/rspb.2013.0077","volume":"280","author":"K Stingl","year":"2013","unstructured":"Stingl K, Bartz-Schmidt KU, Besch D et al (2013) Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS. Proc Biol Sci 280(1757):20130077\u201320130077. https:\/\/doi.org\/10.1098\/rspb.2013.0077","journal-title":"Proc Biol Sci"},{"key":"33_CR27","first-page":"120","volume":"108","author":"AY Chow","year":"2010","unstructured":"Chow AY, Bittner AK, Pardue MT (2010) The artificial silicon retina in retinitis pigmentosa patients (an American Ophthalmological Association thesis). Trans Am Ophthalmol Soc 108:120\u2013154","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"8","key":"33_CR28","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.ophtha.2015.04.032","volume":"122","author":"AC Ho","year":"2015","unstructured":"Ho AC, Humayun MS, Dorn JD et al (2015) Long-term results from an epiretinal prosthesis to restore sight to the blind. Ophthalmology 122(8):1547\u20131554. https:\/\/doi.org\/10.1016\/j.ophtha.2015.04.032","journal-title":"Ophthalmology"},{"issue":"4","key":"33_CR29","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ophtha.2011.09.028","volume":"119","author":"MS Humayun","year":"2012","unstructured":"Humayun MS, Dorn JD, da Cruz L et al (2012) Interim results from the international trial of Second Sight\u2019s visual prosthesis. Ophthalmology 119(4):779\u2013788. https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.028","journal-title":"Ophthalmology"},{"key":"33_CR30","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2147\/OPTH.S137525","volume":"12","author":"AP Finn","year":"2018","unstructured":"Finn AP, Grewal DS, Vajzovic L (2018) Argus II retinal prosthesis system: a review of patient selection criteria, surgical considerations, and post-operative outcomes. Clin Ophthalmol 12:1089\u20131097. https:\/\/doi.org\/10.2147\/OPTH.S137525","journal-title":"Clin Ophthalmol"}],"container-title":["Methods in Molecular Biology","Retinitis Pigmentosa"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2651-1_33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T04:00:25Z","timestamp":1674273625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2651-1_33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"ISBN":["9781071626504","9781071626511"],"references-count":30,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2651-1_33","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"9 December 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}